:: Class Utilisation Summary 2013
See LEGEND for key to shading and symbols.
:: Subject Area - PHAR Term - Semester 2
PHAR2011 | PHAR2211 | PHAR3101 | PHAR3202 | PHAR3306 | PHAR9103 |
PHAR9104 | PHAR9108 | PHAR9109 | PHAR9112 | PHAR9113 | PHAR9116 |
PHAR9124 | PHAR9127 | PHAR9128 |
Data is correct as at Sun Oct 20 19:05:42 EST 2013
Comp | Sect | Class | Type | Status | Enr/Cap | % Full | Times (weeks, Location) - default 1hour |
PHAR2011 | Introductory Pharmacology and | ||||||
LAB | M10A | 3802 | Enr | Full | 93/93 | 100% | Mon 10-13 (w1,3,5,7,9,11, Wurth 115) |
LAB | M10B | 3803 | Enr | Open | 92/94 | 98% | Mon 10-13 (w1-2,4,6,8,10, Wurth 115) |
LAB | M14A | 3804 | Enr | Open | 98/99 | 99% | Mon 14-17 (w1,3,5,7,9,11, Wurth 115) |
LEC | A | 3801 | Rel | Open | 283/290 | 98% | Mon 17 (w1-9,11-13, Clancy Aud); Thu 13 (w1-9,10-12, MathewsThA) Comb/w PHAR2211 |
TUT | F09A | 3808 | Rel | Full | 59/59 | 100% | Fri 09 (w2-9,10-13, Mat 102) |
TUT | F12A | 3809 | Rel | Full | 59/59 | 100% | Fri 12 (w2-9,10-13, Mat 102) |
TUT | W13A | 3805 | Rel | Open | 56/57 | 98% | Wed 13 (w2-9,10-13, Mat 102) |
TUT | W13B | 3807 | Rel | Open | 56/57 | 98% | Wed 13 (w2-9,10-13, WurthLG03) |
TUT | W17A | 3806 | Rel | Open | 53/54 | 98% | Wed 17 (w2-9,10-13, WurthLG02) |
PHAR2211 | Pharmacology for HESC | ||||||
LAB | M14A | 7492 | Enr | Open | 81/90 | 90% | Mon 14-17 (w1-2,4,6,8,10,12, Wurth 115); Mon 14-17 (w1, Wurth 116) |
LEC | A | 7491 | Rel | Open | 81/90 | 90% | Mon 17 (w1-9,11-13, Clancy Aud); Thu 13 (w1-9,10-12, MathewsThA) Comb/w PHAR2011 |
TUT | F10A | 7493 | Rel | Full | 81/81 | 100% | Fri 10-12 (w2-9,10-13, CLB 1) |
PHAR3101 | Rational Drug Design | ||||||
LAB | W14A | 5396 | Enr | Open | 58/65 | 89% | Wed 14-17 (w2-3,5-7,10-11, Wurth 116) |
LEC | A | 5395 | Rel | Open | 58/65 | 89% | Tue 09 (w1-9,10-12, WurthLG02); Thu 12 (w1-9,10-12, WurthLG02) |
TUT | T10A | 5398 | Rel | Open | 30/35 | 86% | Tue 10 (w2-9,10-13, WurthLG02) |
TUT | T15A | 5397 | Rel | Open | 28/29 | 97% | Tue 15 (w2-9,10-13, Mat 306) |
PHAR3202 | Neuropharmacology | ||||||
LAB | T10A | 6966 | Enr | Open | 32/40 | 80% | Tue 10-13 (w2-9,10-13, Wurth 120) |
LAB | T14A | 6967 | Enr | Open | 32/40 | 80% | Tue 14-17 (w2-9,10-13, Wurth 120) |
LE1 | A | 6965 | Rel | Open | 64/80 | 80% | Thu 10 (w1-9,10-12, Biomed ThF); Thu 15 (w1-9,10-12, Biomed ThF) |
TUT | F13A | 6968 | Rel | Open | 36/40 | 90% | Fri 13 (w1-9,10-12, Mat 232) |
TUT | F14A | 6969 | Rel | Open | 28/40 | 70% | Fri 14 (w1-9,10-12, Mat 232) |
PHAR3306 | Pharmacology for Optometry | ||||||
LAB | H14A | 6971 | Enr | Open | 64/70 | 91% | Thu 14-17 (w3,5,9,11,13, WurthG06) |
LEC | A | 6970 | Rel | Open | 64/70 | 91% | Tue 16-18 (w1-9,10-12, WurthLG02); Fri 09 (w1-9,10-12, Biomed ThF) |
TUT | H14B | 6972 | Rel | Full | 40/40 | 100% | Thu 14-16 (w2,4,6,8,10,12, Mat 102) |
TUT | H14C | 6973 | Rel | Open | 24/40 | 60% | Thu 14-16 (w2,4,6,8,10,12, Mat 312) |
PHAR9103 | Biostatistics and Trial Design | ||||||
OTH | 01 | 1458 | Enr | Open | 15/30 | 50% | |
PHAR9104 | Legal/Regulatory Devlp of Med | ||||||
LEC | 01 | 1455 | Enr | Open | 16/30 | 53% | |
PHAR9108 | Therapeutic Basis of Drug Use | ||||||
LEC | 01 | 1459 | Enr | Open | 7/30 | 23% | |
PHAR9109 | Therapeutic Basis of Drug Use | ||||||
LEC | 01 | 1460 | Enr | Open* | 0/20 | 0% | |
PHAR9112 | Advanced Pharmacokinetics | ||||||
LEC | 01 | 1461 | Enr | Open* | 0/20 | 0% | |
PHAR9113 | Advanced Regulatory Affairs | ||||||
LEC | 01 | 1462 | Enr | Open | 15/30 | 50% | |
PHAR9116 | Advanced Clinical Trials Mgmt | ||||||
LEC | 01 | 8818 | Enr | Open | 7/30 | 23% | |
PHAR9124 | Economic Drivers | ||||||
OTH | 01 | 1457 | Enr | Open* | 0/6 | 0% | |
PHAR9127 | Safety and Efficacy | ||||||
OTH | 01 | 1454 | Enr | Open | 15/30 | 50% | |
PHAR9128 | R & D | ||||||
OTH | 01 | 1456 | Enr | Open | 14/25 | 56% | |
^ top ^ | |||||||
LEGEND | |||||||
* This class requires consent. Students cannot self-enrol. | |||||||
# Timetable clash allowed. | |||||||
/odd Runs in odd weeks only. /even Runs in even weeks only. | |||||||
Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity. | |||||||
Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes. | |||||||
[ ] Class capacity where different from effective capacity. | |||||||
Shaded cells: | LEC | Activity different from previous | |||||
Stop | Status is Stop Further Enrolment, Tentative, Closed or Cancelled | ||||||
100% | Class is full (> 100% means capacity is exceeded) | ||||||
80% | Class is nearly full (80% or more) | ||||||
50% | Class is half full | ||||||
0% | Class is less than half full | ||||||
UNSW Sydney NSW 2052, Australian Telephone: (within Aust) 02 9385 1000, (International) +61 2 9385 1000 CRICOS Provider Code 00098G Authorised by Deputy Vice Chancellor (Academic) & Registrar Privacy Statement Copyright & Disclaimer |